Denmark's Lundbeck To Pay $658M For Chelsea Therapeutics
H. Lundbeck A/S is set to acquire Chelsea Therapeutics International Ltd. for about $658 million, the companies said on Thursday, in a deal that gives Lundbeck control of an upcoming treatment...To view the full article, register now.
Already a subscriber? Click here to view full article